Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Kakel Max | KAKEL | 22. nov 2024 | 9.95 | +3.65 |
Kallebäck Property Invest | KAPIAB | 22. nov 2024 | 177.50 | +0.85 |
Kambi Group | KAMBI | 22. nov 2024 | 107.70 | +0.56 |
Kancera | KAN | 22. nov 2024 | 1.06 | -1.30 |
Karnell Group AB (publ) | KARNELB | 22. nov 2024 | 43.75 | +1.27 |
Karnov Group | KAR | 22. nov 2024 | 80.60 | +1.38 |
Karolinska Development B | KDEV | 22. nov 2024 | 1.04 | -3.87 |
Katalysen Ventures AB | KAV | 22. nov 2024 | 12.00 | -8.40 |
KebNi B | KEBNIB | 22. nov 2024 | 0.94 | +3.41 |
Kentima Holding B | KENH | 22. nov 2024 | 2.10 | -3.67 |
Kiliaro | KILI | 22. nov 2024 | 0.24 | -0.42 |
Kinda Brave | BRAVE | 22. nov 2024 | 1.57 | -8.19 |
Kindred Group SDB | KINDSDB | 22. nov 2024 | 129.10 | 0.00 |
Kinnevik A | KINVA | 22. nov 2024 | 75.92 | +0.24 |
Kinnevik B | KINVB | 22. nov 2024 | 75.34 | +0.53 |
Kjell Group | KJELL | 22. nov 2024 | 11.55 | -0.43 |
KlaraBo | KLARAB | 22. nov 2024 | 19.88 | +0.91 |
Klaria Pharma Holding | KLAR | 22. nov 2024 | 0.40 | +5.87 |
Klimator | KLIMAT | 22. nov 2024 | 2.10 | -0.94 |
Knowit | KNOW | 22. nov 2024 | 133.40 | +1.83 |
Kontigo Care | KONT | 22. nov 2024 | 2.60 | -2.26 |
Kopparbergs B | KOBRB | 22. nov 2024 | 112.00 | -0.89 |
Krona Public Real Estate | KRONA | 22. nov 2024 | 48.20 | 0.00 |
Kvix | KVIX | 22. nov 2024 | 0.52 | +7.00 |
Lagercrantz Group B | LAGRB | 22. nov 2024 | 193.80 | +0.16 |
Lammhults Design Group B | LAMMB | 22. nov 2024 | 23.30 | +6.88 |
Lappland Guldprospektering AB | LGOLDB | 0.00 | 0.00 | |
Latour B | LATOB | 22. nov 2024 | 273.90 | +1.26 |
LC-Tec Holding | LCT | 22. nov 2024 | 0.12 | -17.45 |
Leading Edge Materials Corp. | LEMSE | 22. nov 2024 | 0.77 | -0.26 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.